A Single Institution's 10 Year Experience of Treating High Grade Superficial Transitional Cell Carcinoma and Carcinoma In Situ of the Bladder with Intravesical BCG

References

• Morales , A. , Eidinger , D. and Brace , A.W. 1976 . “Intracavity BCG in the treatment of superficial bladder tumours” . J. Urol. , 116 : 180 – 183 .
   PubMed Web of Science ®Google Scholar
• Lamm , D.L. , Thor , D.E. , Harris , S.C. , Reyna , I.A. , Stogdill , VD. and Radwin , H.M. 1980 . “BCG immunotherapy of superficial bladder cancer” . J. Urol. , 124 : 38 – 40 .
   PubMed Web of Science ®Google Scholar
• Bretton , P.R. , Herr , H.W. , Kimmel , M. , Whitmore , W.F. , Laudone , V.P. , Oettgen , H.F. and Fair , W.R. 1990 . “The response of patients with superficial bladder carcinoma to a second course of intravesical bacillus Calmette-Guerin” . J. Urol. , 143 : 710 – 713 .
   Google Scholar
• Brosman , S.A. 1985 . “The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ” . J. Urol. , 134 : 36 – 39 .
   PubMedGoogle Scholar
• Boccon-Gibod , L. , Leleu , C. , Herve , J.M. , Belas , M. and Steg , A. 1989 . “Bladder tumours invading the lamina propria (Stage a/T1 ). Influence of endovesical BCG therapy on recurrence and progression” . EUT. Urol. , 16 : 401 – 404 .
   Google Scholar
• Catalona , W.I. , Hudson , M.A. , Gillen , D.P. , Andriole , G.L. and Ratliff , TL. 1987 . “Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer” . J. Urol. , 137 : 220 – 224 .
   PubMed Web of Science ®Google Scholar
• Herr , H.W. , Pinsky , C.M. , Whitmore , W.F. , Oettgen , H.F. and Melamed , M.R. 1983 . “Effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder” . Cancer , 51 : 1323 – 1326 .
   PubMed Web of Science ®Google Scholar
• Kavoussi , L.R. , Torrence , R.J. , Gillen , D.P. , Hudson , M.A. , Haaff , E.O. , Dresner , S.M. , Ratliff , TL. and Catalona , W.J. 1988 . “Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumours” . J. Urol. , 139 : 935 – 940 .
   PubMedGoogle Scholar
• Morales , A. 1984 . “Long term results and complications of intracavity bacillus Calmette-Guerin therapy for bladder cancer” . J. Urol. , 132 : 457 – 459 .
   PubMed Web of Science ®Google Scholar
• Pinsky , C.M. , Camacho , F.J. , Kerr , D. , Geller , N.L. , Klein , F.A. , Herr , H.W. , Whitmore , W.F. and Oettgen , H.F. 1985 . “Intravesical administration of BCG in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective randomised trial” . Cancer Treat. Rep. , 69 : 47 – 53 .
   PubMedGoogle Scholar
• Herr , H.W. , Pinsky , C.M. , Whitmore , W.F , Sogani , P.C. , Oettgen , H.F. and Melamed , M.R. 1986 . “Long term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder” . J. Urol. , 135 : 265
   PubMed Web of Science ®Google Scholar
• Merz , VW , Marth , D. , Kraft , R. , Ackermann , D.K. , Zingg , E.J. and Struder , U.E. 1995 . “Analysis of early failures after intravesical installation therapy with BCG for carcinoma in situ of the bladder” . BJU , 75 : 180 – 184 .
   Google Scholar
• Herr , H.W. 1997 . “Tumour progression and survival in patients with T1 G3 bladder tumours: 15 year outcome” . BJU , 80 : 762 – 765 .
   Google Scholar
• Brake , M. , Loertzer , H. , Horsh , R. and Keller , H. 2000 . “Long term results of intravesical BCG therapy for stage Tl superficial bladder cancer” . Urology , 55 : 673 – 678 .
   PubMed Web of Science ®Google Scholar
• Lebret , T , Bohin , D. and Kassardijian , Z. 2000 . “Recurrence, progression and success in state Tl grade 3 bladder tumours treated with low dose BCG” . J. Urol. , 163 : 63 – 67 .
   PubMed Web of Science ®Google Scholar
• Baniel , J. , Grauss , D. , Englelstein , D. and Stella , A. 1998 . “Intravesical BCG treatment for stage T1 G3 transitional cell carcinoma of the bladder” . Urology , 52 : 785
   Google Scholar
• Hurle , R. , Losa , A. , Manzetti , A. and Lembo , A. 1999 . “Intravesical BCG in stage Tl grade 3 bladder cancer therapy: a 7 year follow up” . Urology , 54 : 258 – 263 .
   PubMed Web of Science ®Google Scholar
• Ratliff , T.L. , Hudson , M.A. and Catalona , W.J. 1991 . “Strategy for improving therapy of superficial bladder cancer” . World J. Urol. , 9 : 95 – 98 .
   Google Scholar